June 5, 2013, the European Union’s MRL amendment Commission Regulation (EU) No 500/2013 entered into force.
This regulation raises MRLs for the following active ingredients: acetamiprid, Adoxophyes orana granulovirus strain BV-0001, azoxystrobin, clothianidin, fenpyrazamine, heptamaloxyloglucan, metrafenone, Paecilomyces lilacinus strain 251, propiconazole, quizalofop-P, spiromesifen, tebuconazole, thiamethoxam and zucchini yellow mosaik virus - weak strain.
